Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Céline Frantz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Environmental and Molecular Mutagenesis|February 23, 2010
Mitochondria as a target in treatmentMarie-Céline Frantz, Peter Wipf
Biofactors (Oxford, England)|October 19, 2022
NRF2 in dermo-cosmetic: From scientific knowledge to skin care productsMarie-Céline Frantz, Roger Rozot, Laurent Marrot
Journal of Medicinal Chemistry|January 29, 2010
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonistMarie-Céline Frantz, Jordi Rodrigo, Laure Boudier, et al.
Organic Letters|April 2, 2011
Large-scale asymmetric synthesis of the bioprotective agent JP4-039 and analogsMarie-Céline Frantz, Joshua G Pierce, Joan M Pierce, et al.
Journal of Molecular Modeling|October 1, 2016
Benchmarking the DFT methodology for assessing antioxidant-related properties: quercetin and edaravone as case studiesMario Vincenzo La Rocca, Malvina Rutkowski, Stéphanie Ringeissen, et al.
Organic & Biomolecular Chemistry|May 30, 2013
Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondriaMarie-Céline Frantz, Erin M Skoda, Joshua R Sacher, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 3, 2008
Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligandDominique Bonnet, Stéphanie Riché, Stéphanie Loison, et al.
Journal of the American Society of Nephrology : JASN|September 5, 2009
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidusFrédéric Jean-Alphonse, Sanja Perkovska, Marie-Céline Frantz, et al.
Pharmaceutics|January 24, 2012
Design, Synthesis, and Biological Evaluation of PKD InhibitorsKara M George, Marie-Céline Frantz, Karla Bravo-Altamirano, et al.
ACS Medicinal Chemistry Letters|May 28, 2011
Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase DKarla Bravo-Altamirano, Kara M George, Marie-Céline Frantz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Environmental and Molecular Mutagenesis|February 23, 2010
Mitochondria as a target in treatmentMarie-Céline Frantz, Peter Wipf
Biofactors (Oxford, England)|October 19, 2022
NRF2 in dermo-cosmetic: From scientific knowledge to skin care productsMarie-Céline Frantz, Roger Rozot, Laurent Marrot
Journal of Medicinal Chemistry|January 29, 2010
Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonistMarie-Céline Frantz, Jordi Rodrigo, Laure Boudier, et al.
Organic Letters|April 2, 2011
Large-scale asymmetric synthesis of the bioprotective agent JP4-039 and analogsMarie-Céline Frantz, Joshua G Pierce, Joan M Pierce, et al.
Journal of Molecular Modeling|October 1, 2016
Benchmarking the DFT methodology for assessing antioxidant-related properties: quercetin and edaravone as case studiesMario Vincenzo La Rocca, Malvina Rutkowski, Stéphanie Ringeissen, et al.
Organic & Biomolecular Chemistry|May 30, 2013
Synthesis of analogs of the radiation mitigator JP4-039 and visualization of BODIPY derivatives in mitochondriaMarie-Céline Frantz, Erin M Skoda, Joshua R Sacher, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 3, 2008
Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligandDominique Bonnet, Stéphanie Riché, Stéphanie Loison, et al.
Journal of the American Society of Nephrology : JASN|September 5, 2009
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidusFrédéric Jean-Alphonse, Sanja Perkovska, Marie-Céline Frantz, et al.
Pharmaceutics|January 24, 2012
Design, Synthesis, and Biological Evaluation of PKD InhibitorsKara M George, Marie-Céline Frantz, Karla Bravo-Altamirano, et al.
ACS Medicinal Chemistry Letters|May 28, 2011
Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase DKarla Bravo-Altamirano, Kara M George, Marie-Céline Frantz, et al.
Pageof 2